perflubron has been researched along with paclitaxel in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hou, L; Li, L; Li, X; Mo, L; Qin, F; Yang, L | 1 |
| Boissenot, T; Bordat, A; Chacun, H; Fattal, E; Gueutin, C; Houvenagel, S; Tsapis, N; Valette, J | 1 |
| Boissenot, T; Bordat, A; Chacun, H; Fattal, E; Larrat, B; Paci, A; Poinsignon, V; Tsapis, N; Varna, M | 1 |
4 other study(ies) available for perflubron and paclitaxel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Carriers; Female; Fluorocarbons; Hydrocarbons, Brominated; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Sulfoglycosphingolipids; Tissue Distribution | 2014 |
Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Colonic Neoplasms; Cryoelectron Microscopy; Drug Carriers; Drug Delivery Systems; Female; Fluorocarbons; Hydrocarbons, Brominated; Inhibitory Concentration 50; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanocapsules; Neoplasm Transplantation; Paclitaxel; Particle Size; Polyethylene Glycols; Theranostic Nanomedicine | 2016 |
Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Combined Modality Therapy; Female; Fluorocarbons; Hydrocarbons, Brominated; Hyperthermia, Induced; Mice, Nude; Nanocapsules; Neoplasms; Paclitaxel; Polyethylene Glycols; Polyglactin 910; Tissue Distribution; Treatment Outcome; Ultrasonic Therapy | 2017 |